ASRGL1 Antibody (CRASH/1290) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08327R
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # CRASH/1290
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ASRGL1 Antibody (CRASH/1290) [DyLight 550]
Immunogen
Recombinant human ASRGL1 fragment (Uniprot: Q7L266)
Localization
Cytoplasmic and Nuclear
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for ASRGL1 Antibody (CRASH/1290) [DyLight 550]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ASRGL1
Alternate Names
ALP1, ALPL-asparagine amidohydrolase, asparaginase like 1, asparaginase-like 1 protein, Asparaginase-like protein 1, CRASH, EC 3.5.1.1, FLJ22316, L-asparaginase
Gene Symbol
ASRGL1
Additional ASRGL1 Products
Product Documents for ASRGL1 Antibody (CRASH/1290) [DyLight 550]
Product Specific Notices for ASRGL1 Antibody (CRASH/1290) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...